Conley BA - Search Results

1

Ratain MJ, Schilsky RL, Conley BA, Egorin MJ. Ratain MJ, et al. Among authors: conley ba. J Clin Oncol. 1990 Oct;8(10):1739-53. doi: 10.1200/JCO.1990.8.10.1739. J Clin Oncol. 1990. PMID: 2213109 Review.

2

Development and use of integral assays in clinical trials.

Schilsky RL, Doroshow JH, Leblanc M, Conley BA. Schilsky RL, et al. Among authors: conley ba. Clin Cancer Res. 2012 Mar 15;18(6):1540-6. doi: 10.1158/1078-0432.CCR-11-2202. Clin Cancer Res. 2012. PMID: 22422406 Free PMC article.

3

Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, O'Hara S, Wu S, Melink TJ, Parnes H, Pardoe E, Egorin MJ, Van Echo DA. Conley BA, et al. Cancer Chemother Pharmacol. 1995;37(1-2):139-49. doi: 10.1007/BF00685641. Cancer Chemother Pharmacol. 1995. PMID: 7497583 Clinical Trial.

4

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, Egorin MJ, Sridhara R, Finley R, Hemady R, Wu S, Tait NS, Van Echo DA. Conley BA, et al. Cancer Chemother Pharmacol. 1997;39(4):291-9. doi: 10.1007/s002800050575. Cancer Chemother Pharmacol. 1997. PMID: 9025769 Clinical Trial.

5

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.

Conley BA, Egorin MJ, Tait N, Rosen DM, Sausville EA, Dover G, Fram RJ, Van Echo DA. Conley BA, et al. Clin Cancer Res. 1998 Mar;4(3):629-34. Clin Cancer Res. 1998. PMID: 9533530 Clinical Trial.

6

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580).

Conley BA, Forrest A, Egorin MJ, Zuhowski EG, Sinibaldi V, Van Echo DA. Conley BA, et al. Cancer Res. 1989 Jun 15;49(12):3436-40. Cancer Res. 1989. PMID: 2720696

7

Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.

Aisner J, Belani CP, Kearns C, Conley B, Hiponia D, Engstrom C, Zuhowski E, Egorin MJ. Aisner J, et al. Semin Oncol. 1995 Oct;22(5 Suppl 12):17-21. Semin Oncol. 1995. PMID: 7481856 Clinical Trial.

8

Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.

Conley BA, Egorin MJ, Sinibaldi V, Van Echo DA. Conley BA, et al. Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592. Invest New Drugs. 1990. PMID: 2150671 Clinical Trial. No abstract available.

9

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.

Egorin MJ, Conley BA, Forrest A, Zuhowski EG, Sinibaldi V, Van Echo DA. Egorin MJ, et al. Among authors: conley ba. Cancer Res. 1987 Nov 15;47(22):6104-10. Cancer Res. 1987. PMID: 2959359

10

An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.

Subramanyam B, Callery PS, Egorin MJ, Snyder SW, Conley BA. Subramanyam B, et al. Among authors: conley ba. Drug Metab Dispos. 1989 Jul-Aug;17(4):398-401. Drug Metab Dispos. 1989. PMID: 2571479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters